Evogene Reports Third Quarter 2025 Financial Results
22 November 2025, Israel: Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small
Read More
Evogene
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
12 November 2025, Israel: Casterra Ag Ltd. (“Casterra”), an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions —
Read More
Evogene Reports Second Quarter 2025 Financial Results
21 August 2025, Israel: Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company aiming to revolutionize the development of
Read More
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
13 August 2025, Israel: Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company, today announced a scientific collaboration with the
Read More
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL
09 July 2025, Israel: Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to
Read More
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
12 June 2025, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and
Read More
Evogene Reports First Quarter 2025 Financial Results
22 May 2025, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based
Read More
Evogene Schedules First Quarter 2025 Financial Results Release
10 May 2025, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and
Read More
ICL to Acquire the Activity of Evogene’s subsidiary, Lavie Bio
22 April 2025, Israel: Evogene Ltd., a computational biology company focused on life-science-based product discovery and development announced the signing of a definitive
Read More
Evogene Schedules Fourth Quarter 2024 Financial Results Release
21 February 2025, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and
Read More